scholarly journals Status and Perspectives of Commercial Aircraft Morphing

Biomimetics ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 11
Author(s):  
Michelangelo Giuliani ◽  
Ignazio Dimino ◽  
Salvatore Ameduri ◽  
Rosario Pecora ◽  
Antonio Concilio

In a previous paper, the authors dealt with the current showstoppers that inhibit commercial applicability of morphing systems. In this work, the authors express a critical vision of the current status of the proposed architectures and the needs that should be accomplished to make them viable for installation onboard of commercial aircraft. The distinction is essential because military and civil issues and necessities are very different, and both the solutions and difficulties to be overcome are widely diverse. Yet, still remaining in the civil segment, there can be other differences, depending on the size of the aircraft, from large jets to commuters or general aviation, which are classifiable in tourism, acrobatic, ultralight, and so on, each with their own peculiarities. Therefore, the paper aims to trace a common technology denominator, if possible, and envisage a future perspective of actual applications.

Author(s):  
Michelangelo Giuliani ◽  
Ignazio Dimino ◽  
Salvatore Ameduri ◽  
Rosario Pecora ◽  
Antonio Concilio

In a previous paper, the authors dealt with the current showstoppers for morphing systems and with the reasons that have inhibited their commercial applicability. In this work, the authors ex-press a critical vision of the current status of the proposed architectures and the needs that should be accomplished to make them viable for installation onboard of commercial aircraft. The distinc-tion is essential because military and civil issues and necessities are very different, and both the solutions and difficulties to be overcome are widely diverse. Yet, still remaining in the civil seg-ment, there can be other differences, depending on the size of the aircraft, from large jets to com-muters or general aviation, in turn classifiable in tourism, acrobatic, ultralight and so on, each with their own peculiarities. Therefore, the paper wants to try to trace a common technology de-nominator, if possible, and envisage a future perspective of actual applications.


2019 ◽  
Vol 20 (12) ◽  
pp. 1227-1243
Author(s):  
Hina Qamar ◽  
Sumbul Rehman ◽  
D.K. Chauhan

Cancer is the second leading cause of morbidity and mortality worldwide. Although chemotherapy and radiotherapy enhance the survival rate of cancerous patients but they have several acute toxic effects. Therefore, there is a need to search for new anticancer agents having better efficacy and lesser side effects. In this regard, herbal treatment is found to be a safe method for treating and preventing cancer. Here, an attempt has been made to screen some less explored medicinal plants like Ammania baccifera, Asclepias curassavica, Azadarichta indica, Butea monosperma, Croton tiglium, Hedera nepalensis, Jatropha curcas, Momordica charantia, Moringa oleifera, Psidium guajava, etc. having potent anticancer activity with minimum cytotoxic value (IC50 >3μM) and lesser or negligible toxicity. They are rich in active phytochemicals with a wide range of drug targets. In this study, these medicinal plants were evaluated for dose-dependent cytotoxicological studies via in vitro MTT assay and in vivo tumor models along with some more plants which are reported to have IC50 value in the range of 0.019-0.528 mg/ml. The findings indicate that these plants inhibit tumor growth by their antiproliferative, pro-apoptotic, anti-metastatic and anti-angiogenic molecular targets. They are widely used because of their easy availability, affordable price and having no or sometimes minimal side effects. This review provides a baseline for the discovery of anticancer drugs from medicinal plants having minimum cytotoxic value with minimal side effects and establishment of their analogues for the welfare of mankind.


Author(s):  
Jiawei Wang ◽  
Yu Zhang ◽  
Niloofar Heshmati Aghda ◽  
Amit Raviraj Pillai ◽  
Rishi Thakkar ◽  
...  

2021 ◽  
Author(s):  
Katsuhiro Mabe ◽  
Kazuhiko Inoue ◽  
Tomoari Kamada ◽  
Katsuaki Kato ◽  
Mototsugu Kato ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document